Page last updated: 2024-08-23

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Retinal Degeneration

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Retinal Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hara, H; Imai, S; Nakanishi, T; Shimazawa, M; Tsuruma, K; Umigai, N; Yamauchi, M1

Other Studies

1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Retinal Degeneration

ArticleYear
Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity.
    European journal of pharmacology, 2011, Jan-10, Volume: 650, Issue:1

    Topics: Administration, Oral; Animals; Carotenoids; Caspase Inhibitors; Caspases; Cell Death; Cell Line; Chromans; Endoplasmic Reticulum; Enzyme Activation; Enzyme Inhibitors; Fluoresceins; Gene Expression Regulation; Humans; Hydrogen Peroxide; Intracellular Space; Light; Male; Membrane Potential, Mitochondrial; Mice; Oxidation-Reduction; Oxidative Stress; Photoreceptor Cells, Vertebrate; Rats; Retinal Degeneration; Retinal Ganglion Cells; Tunicamycin; Vitamin A; Xanthenes

2011